
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading research university in Germany is offering a fully funded PhD position focused on developing microfluidic systems for early cancer detection. This role is geared towards candidates with a strong master's degree in biomedical engineering or related fields, aiming to advance cancer diagnostics through innovative research. Ideal candidates should possess hands-on experience with prototyping techniques and a motivation to work at the interface of engineering and life sciences. Join this prestigious program to make a significant impact in biomedical research.
University: Heidelberg University
Country: Germany
Deadline: 2026-01-31
Fields: Biomedical Engineering, Mechanical Engineering, Electrical Engineering, Physics, Molecular Biotechnology
Are you driven by the ambition to revolutionize cancer diagnostics through innovative engineering and biomedical research? If you are eager to contribute to the development of cutting‑edge microfluidic systems for early cancer detection, this fully funded PhD position at Heidelberg University could be your gateway to a transformative academic and professional journey.
Heidelberg University, established in 1386, is Germany’s oldest university and one of Europe’s leading research institutions. Located in the picturesque city of Heidelberg, the university is renowned for its vibrant academic atmosphere, robust international collaborations, and commitment to interdisciplinary research. With around 31,300 students and 8,400 employees, the university is a cornerstone of the Rhine‑Neckar metropolitan region and consistently ranks among the top universities globally. Students and researchers benefit from state‑of‑the‑art facilities, a supportive academic environment, and access to a dynamic scientific community.
The primary research focus of this PhD position is the development of innovative acoustofluidic systems for the enrichment of extracellular vesicles (EVs) from microlitre samples. EVs are emerging as powerful biomarkers for early cancer detection, offering non‑invasive, sensitive, and specific insights into disease states. However, isolating and analysing EVs efficiently remains a significant technical challenge. By advancing the physical and engineering foundations of microfluidic EV isolation, this project aims to pave the way for breakthrough applications in cancer diagnostics and therapies. The outcomes of this research have the potential to transform clinical workflows, improve patient outcomes, and contribute to the broader field of biomedical engineering.
This is a unique opportunity to join a world‑class research university in Germany and contribute to the advancement of early cancer detection technologies. If you are motivated to work at the interface of engineering and life sciences and aspire to make a tangible impact in biomedical research, consider applying for this prestigious PhD position at Heidelberg University.
For further information, visit the official position page: https://www.imseam.uni-heidelberg.de/de/node/1384